Literature DB >> 1846263

AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization.

S J Hamilton-Dutoit1, G Pallesen, M B Franzmann, J Karkov, F Black, P Skinhøj, C Pedersen.   

Abstract

To investigate the range of pathology shown by acquired immune deficiency syndrome (AIDS)-related lymphomas arising in an epidemiologically well-defined group of patients, all cases of lymphoma recognized in Danish human immunodeficiency virus (HIV)-infected individuals up to the end of 1988 were studied. Twenty-seven cases (26 high-grade non-Hodgkin's lymphoma [NHL], 1 Hodgkin's disease) were found, to give a cumulative incidence rate of 8% among Danish AIDS patients. Morphologically most NHL patients were classified into two groups: 1) high-grade tumors with a predominant population of immunoblasts, either monomorphic or more often polymorphic with plasmacytic differentiation; 2) Burkitt-type. Of 26 NHLs, 22 had a B-cell paraffin-section immunophenotype and 4 were non-B, non-T. Epstein-Barr virus (EBV) DNA was demonstrated in tumor cells of 12 of 24 cases (50%) using in situ nucleic acid hybridization with a 35S-labeled probe in paraffin sections. Epstein-Barr virus DNA was found in 65% of group 1 and 20% of group 2 tumors. This study suggests the existence of two main groups of AIDS-related lymphoma with different pathogeneses. First there are immunoblast-rich lesions, which usually are associated with EBV and morphologically resemble lymphomas described in immunosuppressed organ-transplantation patients. Second there are Burkitt-type tumors in which EBV sequences are less common and that may be pathogenetically analogous to sporadic Burkitt's lymphoma.

Entities:  

Mesh:

Year:  1991        PMID: 1846263      PMCID: PMC1886047     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  58 in total

1.  Polyclonal activation of B cells in homosexual men.

Authors: 
Journal:  N Engl J Med       Date:  1984-08-23       Impact factor: 91.245

2.  Lymphoma in cardiac allotransplant recipients. Clinical and histological features and immunological phenotype.

Authors:  J Weintraub; R A Warnke
Journal:  Transplantation       Date:  1982-04       Impact factor: 4.939

3.  A complete set of overlapping cosmid clones of M-ABA virus derived from nasopharyngeal carcinoma and its similarity to other Epstein-Barr virus isolates.

Authors:  A Polack; G Hartl; U Zimber; U K Freese; G Laux; K Takaki; B Hohn; L Gissmann; G W Bornkamm
Journal:  Gene       Date:  1984-03       Impact factor: 3.688

4.  Human cytomegalovirus DNA sequences with homologies to the cellular genome.

Authors:  R Rüger; G W Bornkamm; B Fleckenstein
Journal:  J Gen Virol       Date:  1984-08       Impact factor: 3.891

5.  Epstein-Barr-virus-carrying lymphoma in a patient with ataxia-telangiectasia.

Authors:  A K Saemundsen; A I Berkel; W Henle; G Henle; M Anvret; O Sanal; F Ersoy; M Cağlar; G Klein
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-07

6.  Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas.

Authors:  M L Cleary; J Sklar
Journal:  Lancet       Date:  1984-09-01       Impact factor: 79.321

7.  Development of B-cell lymphoma in homosexual men. Clinical and immunologic findings.

Authors:  A M Levine; P R Meyer; M K Begandy; J W Parker; C R Taylor; L Irwin; R J Lukes
Journal:  Ann Intern Med       Date:  1984-01       Impact factor: 25.391

8.  Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization.

Authors:  A K Saemundsen; D T Purtilo; K Sakamoto; J L Sullivan; A C Synnerholm; D Hanto; R Simmons; M Anvret; R Collins; G Klein
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

9.  Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy.

Authors:  D W Hanto; K J Gajl-Peczalska; G Frizzera; D C Arthur; H H Balfour; K McClain; R L Simmons; J S Najarian
Journal:  Ann Surg       Date:  1983-09       Impact factor: 12.969

10.  Detection of viral genomes in cultured cells and paraffin-embedded tissue sections using biotin-labeled hybridization probes.

Authors:  D J Brigati; D Myerson; J J Leary; B Spalholz; S Z Travis; C K Fong; G D Hsiung; D C Ward
Journal:  Virology       Date:  1983-04-15       Impact factor: 3.616

View more
  43 in total

1.  TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues.

Authors:  M Teitell; M A Damore; G G Sulur; D E Turner; M H Stern; J W Said; C T Denny; R Wall
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Epstein-Barr and human immunodeficiency viruses in acquired immunodeficiency syndrome-related primary central nervous system lymphoma.

Authors:  S Morgello
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

3.  Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity.

Authors:  M L Hammarskjöld; M C Simurda
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

4.  And then there were eight...

Authors:  S D Shafran; J M Conly
Journal:  Can J Infect Dis       Date:  1996-01

Review 5.  Central nervous system infection during immunosuppression.

Authors:  Joseph R Zunt
Journal:  Neurol Clin       Date:  2002-02       Impact factor: 3.806

6.  Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient.

Authors:  Mu-Sheng Zeng; Da-Jiang Li; Qing-Lun Liu; Li-Bing Song; Man-Zhi Li; Ru-Hua Zhang; Xing-Juan Yu; Hui-Min Wang; Ingemar Ernberg; Yi-Xin Zeng
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 7.  Pathogenesis of AIDS-related lymphomas: molecular and histogenetic heterogeneity.

Authors:  G Gaidano; A Carbone; R Dalla-Favera
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

8.  Amplified RPS6KB1 and CDC2 genes are potential biomarkers for aggressive HIV+/EBV+ diffuse large B-cell lymphomas.

Authors:  Xianfeng F Zhao; Merry Y Zhao; Ling Chai; Debra Kukuruga; Ming Tan; Sanford A Stass
Journal:  Int J Clin Exp Pathol       Date:  2013-01-15

9.  Detection of Eber-1 RNA in primary brain lymphomas in immunocompetent and immunocompromised patients.

Authors:  R Bashir; B McManus; C Cunningham; D Weisenburger; F Hochberg
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

10.  Hairy cell leukemia and multiple autoimmune manifestations in a human immunodeficiency virus-infected patient.

Authors:  V R Arruda; J M Bizzacchi; I L Metze
Journal:  Ann Hematol       Date:  1993-06       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.